Research programme: cyclo-oxygenase-2 inhibitors - NitroMed
Alternative Names: COX-2 inhibitors research programme - NitroMed; Cyclo-oxygenase-2 inhibitors research programme - NitroMed; Research programme: COX-2 inhibitors - NitroMedLatest Information Update: 19 Mar 2008
At a glance
- Originator NitroMed
- Class Pyrazoles
- Mechanism of Action Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation; Pain
Most Recent Events
- 19 Mar 2008 Discontinued - Preclinical for Pain in USA (unspecified route)
- 06 Mar 2008 Discontinued - Preclinical for Inflammation in USA (unspecified route)
- 30 Mar 2005 Data presented at the 229th American Chemical Society National Meeting (229th-ACS-2005) have been added to the Inflammation pharmacodynamics section